{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:40:08Z","timestamp":1794332408727,"version":"4.9.0"},"reference-count":179,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AARG-22-974344"],"award-info":[{"award-number":["AARG-22-974344"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82201399"],"award-info":[{"award-number":["82201399"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"DOI":"10.1007\/s00018-025-05686-w","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T06:04:11Z","timestamp":1745820251000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The potential of brain organoids in addressing the heterogeneity of synucleinopathies"],"prefix":"10.1007","volume":"82","author":[{"given":"Xiao-Jun","family":"Diao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Cheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1968-3249","authenticated-orcid":false,"given":"Abhisek","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"5686_CR1","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.3233\/JPD-179005","volume":"7","author":"M Goedert","year":"2017","unstructured":"Goedert M et al (2017) The Synucleinopathies: Twenty Years On. J Parkinsons Dis 7:S51\u2013S69","journal-title":"J Parkinsons Dis"},{"key":"5686_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.nbd.2017.07.018","volume":"109","author":"C Peng","year":"2018","unstructured":"Peng C et al (2018) Distinct \u03b1-Synuclein strains and implications for heterogeneity among \u03b1-Synucleinopathies. Neurobiol Dis 109:209\u2013218","journal-title":"Neurobiol Dis"},{"key":"5686_CR3","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/mds.27193","volume":"32","author":"SA Schneider","year":"2017","unstructured":"Schneider SA et al (2017) Neuropathology of genetic synucleinopathies with parkinsonism: review of the literature. Mov Disord 32:1504\u20131523","journal-title":"Mov Disord"},{"key":"5686_CR4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00401-020-02255-2","volume":"141","author":"J Attems","year":"2021","unstructured":"Attems J et al (2021) Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study. Acta Neuropathol 141:159\u2013172","journal-title":"Acta Neuropathol"},{"key":"5686_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13024-021-00501-z","volume":"16","author":"S Koga","year":"2021","unstructured":"Koga S et al (2021) Neuropathology and molecular diagnosis of synucleinopathies. Mol Neurodegener 16:83","journal-title":"Mol Neurodegener"},{"key":"5686_CR6","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1001\/archneur.63.4.584","volume":"63","author":"S Greffard","year":"2006","unstructured":"Greffard S et al (2006) Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra. Arch Neurol 63:584\u2013588","journal-title":"Arch Neurol"},{"key":"5686_CR7","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1002\/mds.27184","volume":"32","author":"K Kasanuki","year":"2017","unstructured":"Kasanuki K et al (2017) Regional analysis and genetic association of nigrostriatal degeneration in Lewy body disease. Mov Disord 32:1584\u20131593","journal-title":"Mov Disord"},{"key":"5686_CR8","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30:1591\u20131601","journal-title":"Mov Disord"},{"key":"5686_CR9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H et al (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"5686_CR10","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-008-0344-8","volume":"115","author":"G Halliday","year":"2008","unstructured":"Halliday G et al (2008) The progression of pathology in longitudinally followed patients with Parkinson\u2019s disease. Acta Neuropathol 115:409\u2013415","journal-title":"Acta Neuropathol"},{"key":"5686_CR11","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/mds.21956","volume":"23","author":"MA Hely","year":"2008","unstructured":"Hely MA et al (2008) The Sydney multicenter study of Parkinson\u2019s disease: the inevitability of dementia at 20 years. Mov Disord 23:837\u2013844","journal-title":"Mov Disord"},{"key":"5686_CR12","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1002\/mds.23073","volume":"25","author":"E Rosenthal","year":"2010","unstructured":"Rosenthal E et al (2010) Association between cognition and function in patients with Parkinson disease with and without dementia. Mov Disord 25:1170\u20131176","journal-title":"Mov Disord"},{"key":"5686_CR13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12916-018-1016-8","volume":"16","author":"KA Jellinger","year":"2018","unstructured":"Jellinger KA et al (2018) Are dementia with Lewy bodies and Parkinson\u2019s disease dementia the same disease? BMC Med 16:34","journal-title":"BMC Med"},{"key":"5686_CR14","doi-asserted-by":"publisher","first-page":"105557","DOI":"10.1016\/j.nbd.2021.105557","volume":"161","author":"P Borghammer","year":"2021","unstructured":"Borghammer P et al (2021) Neuropathological evidence of body-first vs brain-first Lewy body disease. Neurobiol Dis 161:105557","journal-title":"Neurobiol Dis"},{"issue":"Suppl 2","key":"5686_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000113469","volume":"38","author":"K Wakabayashi","year":"1997","unstructured":"Wakabayashi K et al (1997) Neuropathology of autonomic nervous system in Parkinson\u2019s disease. Eur Neurol 38(Suppl 2):2\u20137","journal-title":"Eur Neurol"},{"key":"5686_CR16","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s00702-021-02355-7","volume":"128","author":"D Erskine","year":"2021","unstructured":"Erskine D et al (2021) Insights into Lewy body disease from rare neurometabolic disorders. J Neural Transm (Vienna) 128:1567\u20131575","journal-title":"J Neural Transm (Vienna)"},{"key":"5686_CR17","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","volume":"71","author":"S Gilman","year":"2008","unstructured":"Gilman S et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670\u2013676","journal-title":"Neurology"},{"key":"5686_CR18","doi-asserted-by":"publisher","first-page":"5535","DOI":"10.1038\/s41467-019-13564-w","volume":"10","author":"T Stroh\u00e4ker","year":"2019","unstructured":"Stroh\u00e4ker T et al (2019) Structural heterogeneity of \u03b1-synuclein fibrils amplified from patient brain extracts. Nat Commun 10:5535","journal-title":"Nat Commun"},{"key":"5686_CR19","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41586-018-0104-4","volume":"557","author":"C Peng","year":"2018","unstructured":"Peng C et al (2018) Cellular milieu imparts distinct pathological \u03b1-synuclein strains in \u03b1-synucleinopathies. Nature 557:558\u2013563","journal-title":"Nature"},{"key":"5686_CR20","doi-asserted-by":"publisher","first-page":"E5308","DOI":"10.1073\/pnas.1514475112","volume":"112","author":"SB Prusiner","year":"2015","unstructured":"Prusiner SB et al (2015) Evidence for \u03b1-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc Natl Acad Sci U S A 112:E5308\u2013E5317","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5686_CR21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","volume":"578","author":"M Shahnawaz","year":"2020","unstructured":"Shahnawaz M et al (2020) Discriminating \u03b1-synuclein strains in Parkinson\u2019s disease and multiple system atrophy. Nature 578:273\u2013277","journal-title":"Nature"},{"key":"5686_CR22","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1074\/jbc.RA118.004471","volume":"294","author":"TR Yamasaki","year":"2019","unstructured":"Yamasaki TR et al (2019) Parkinson\u2019s disease and multiple system atrophy have distinct \u03b1-synuclein seed characteristics. J Biol Chem 294:1045\u20131058","journal-title":"J Biol Chem"},{"key":"5686_CR23","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41586-020-2317-6","volume":"585","author":"M Schweighauser","year":"2020","unstructured":"Schweighauser M et al (2020) Structures of \u03b1-synuclein filaments from multiple system atrophy. Nature 585:464\u2013469","journal-title":"Nature"},{"key":"5686_CR24","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41586-022-05319-3","volume":"610","author":"Y Yang","year":"2022","unstructured":"Yang Y et al (2022) Structures of \u03b1-synuclein filaments from human brains with Lewy pathology. Nature 610:791\u2013795","journal-title":"Nature"},{"key":"5686_CR25","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1212\/WNL.53.9.2003","volume":"53","author":"T G\u00f3mez-Isla","year":"1999","unstructured":"G\u00f3mez-Isla T et al (1999) Clinicopathologic correlates in temporal cortex in dementia with Lewy bodies. Neurology 53:2003\u20132009","journal-title":"Neurology"},{"key":"5686_CR26","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1212\/WNL.53.6.1284","volume":"53","author":"E G\u00f3mez-Tortosa","year":"1999","unstructured":"G\u00f3mez-Tortosa E et al (1999) Clinical and quantitative pathologic correlates of dementia with Lewy bodies. Neurology 53:1284\u20131291","journal-title":"Neurology"},{"key":"5686_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S0006-8993(97)00874-3","volume":"775","author":"MM Tompkins","year":"1997","unstructured":"Tompkins MM et al (1997) Contribution of somal Lewy bodies to neuronal death. Brain Res 775:24\u201329","journal-title":"Brain Res"},{"key":"5686_CR28","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/j.1532-5415.1969.tb01316.x","volume":"17","author":"LS Forno","year":"1969","unstructured":"Forno LS (1969) Concentric hyalin intraneuronal inclusions of Lewy type in the brains of elderly persons (50 incidental cases): relationship to parkinsonism. J Am Geriatr Soc 17:557\u2013575","journal-title":"J Am Geriatr Soc"},{"key":"5686_CR29","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.neuron.2023.01.016","volume":"111","author":"S Balusu","year":"2023","unstructured":"Balusu S et al (2023) Neurodegeneration cell per cell. Neuron 111:767\u2013786","journal-title":"Neuron"},{"key":"5686_CR30","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","volume":"164","author":"B De Strooper","year":"2016","unstructured":"De Strooper B et al (2016) The cellular phase of Alzheimer\u2019s disease. Cell 164:603\u2013615","journal-title":"Cell"},{"key":"5686_CR31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41586-021-03465-8","volume":"598","author":"TE Bakken","year":"2021","unstructured":"Bakken TE et al (2021) Comparative cellular analysis of motor cortex in human, marmoset and mouse. Nature 598:111\u2013119","journal-title":"Nature"},{"key":"5686_CR32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41586-019-1506-7","volume":"573","author":"RD Hodge","year":"2019","unstructured":"Hodge RD et al (2019) Conserved cell types with divergent features in human versus mouse cortex. Nature 573:61\u201368","journal-title":"Nature"},{"issue":"1609\u20131622","key":"5686_CR33","first-page":"e16","volume":"179","author":"L Geirsdottir","year":"2019","unstructured":"Geirsdottir L et al (2019) Cross-species single-cell analysis reveals divergence of the primate microglia program. Cell 179(1609\u20131622):e16","journal-title":"Cell"},{"key":"5686_CR34","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/s41593-020-00730-3","volume":"23","author":"I Chiaradia","year":"2020","unstructured":"Chiaradia I et al (2020) Brain organoids for the study of human neurobiology at the interface of in vitro and in vivo. Nat Neurosci 23:1496\u20131508","journal-title":"Nat Neurosci"},{"key":"5686_CR35","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s41582-022-00723-9","volume":"18","author":"OL Eichm\u00fcller","year":"2022","unstructured":"Eichm\u00fcller OL et al (2022) Human cerebral organoids\u2014a new tool for clinical neurology research. Nat Rev Neurol 18:661\u2013680","journal-title":"Nat Rev Neurol"},{"key":"5686_CR36","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nature25032","volume":"553","author":"SP Pa\u0219ca","year":"2018","unstructured":"Pa\u0219ca SP (2018) The rise of three-dimensional human brain cultures. Nature 553:437\u2013445","journal-title":"Nature"},{"key":"5686_CR37","doi-asserted-by":"publisher","first-page":"e77232","DOI":"10.1371\/journal.pone.0077232","volume":"8","author":"V Hongisto","year":"2013","unstructured":"Hongisto V et al (2013) High-throughput 3D screening reveals differences in drug sensitivities between culture models of JIMT1 breast cancer cells. PLoS ONE 8:e77232","journal-title":"PLoS ONE"},{"key":"5686_CR38","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1089\/adt.2014.573","volume":"12","author":"R Edmondson","year":"2014","unstructured":"Edmondson R et al (2014) Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. Assay Drug Dev Technol 12:207\u2013218","journal-title":"Assay Drug Dev Technol"},{"key":"5686_CR39","doi-asserted-by":"publisher","first-page":"5766","DOI":"10.1038\/s41380-020-0806-5","volume":"26","author":"I Ali\u0107","year":"2021","unstructured":"Ali\u0107 I et al (2021) Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain. Mol Psychiatry 26:5766\u20135788","journal-title":"Mol Psychiatry"},{"key":"5686_CR40","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3390\/cells12040625","volume":"12","author":"A Becerra-Calixto","year":"2023","unstructured":"Becerra-Calixto A et al (2023) Lewy Body-like pathology and loss of dopaminergic neurons in midbrain organoids derived from familial Parkinson\u2019s disease patient. Cells 12:625","journal-title":"Cells"},{"key":"5686_CR41","doi-asserted-by":"publisher","first-page":"4547","DOI":"10.1016\/j.cell.2021.07.003","volume":"184","author":"KR Bowles","year":"2021","unstructured":"Bowles KR et al (2021) ELAVL4, splicing, and glutamatergic dysfunction precede neuron loss in MAPT mutation cerebral organoids. Cell 184:4547-4563.e17","journal-title":"Cell"},{"key":"5686_CR42","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1038\/s41380-018-0229-8","volume":"23","author":"C Gonzalez","year":"2018","unstructured":"Gonzalez C et al (2018) Modeling amyloid beta and tau pathology in human cerebral organoids. Mol Psychiatry 23:2363\u20132374","journal-title":"Mol Psychiatry"},{"key":"5686_CR43","doi-asserted-by":"publisher","first-page":"5540","DOI":"10.1038\/s41467-020-19264-0","volume":"11","author":"J Zhao","year":"2020","unstructured":"Zhao J et al (2020) APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer\u2019s disease patient iPSC-derived cerebral organoids. Nat Commun 11:5540","journal-title":"Nat Commun"},{"key":"5686_CR44","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41467-022-28043-y","volume":"13","author":"B Cakir","year":"2022","unstructured":"Cakir B et al (2022) Expression of the transcription factor PU.1 induces the generation of microglia-like cells in human cortical organoids. Nat Commun 13:430","journal-title":"Nat Commun"},{"key":"5686_CR45","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.3390\/cells10102683","volume":"10","author":"S Ramirez","year":"2021","unstructured":"Ramirez S et al (2021) Modeling traumatic brain injury in human cerebral organoids. Cells 10:2683","journal-title":"Cells"},{"key":"5686_CR46","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.stem.2016.07.005","volume":"19","author":"J Jo","year":"2016","unstructured":"Jo J et al (2016) Midbrain-like organoids from human pluripotent stem cells contain functional dopaminergic and neuromelanin-producing neurons. Cell Stem Cell 19:248\u2013257","journal-title":"Cell Stem Cell"},{"key":"5686_CR47","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.stemcr.2017.03.010","volume":"8","author":"AS Monzel","year":"2017","unstructured":"Monzel AS et al (2017) Derivation of human midbrain-specific organoids from neuroepithelial stem cells. Stem Cell Reports 8:1144\u20131154","journal-title":"Stem Cell Reports"},{"key":"5686_CR48","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.cell.2016.04.032","volume":"165","author":"X Qian","year":"2016","unstructured":"Qian X et al (2016) Brain-region-specific organoids using mini-bioreactors for modeling ZIKV exposure. Cell 165:1238\u20131254","journal-title":"Cell"},{"key":"5686_CR49","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1089\/scd.2013.0442","volume":"23","author":"V Tieng","year":"2014","unstructured":"Tieng V et al (2014) Engineering of midbrain organoids containing long-lived dopaminergic neurons. Stem Cells Dev 23:1535\u20131547","journal-title":"Stem Cells Dev"},{"key":"5686_CR50","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00441-020-03249-y","volume":"382","author":"LM Smits","year":"2020","unstructured":"Smits LM et al (2020) Single-cell transcriptomics reveals multiple neuronal cell types in human midbrain-specific organoids. Cell Tissue Res 382:463\u2013476","journal-title":"Cell Tissue Res"},{"key":"5686_CR51","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41593-022-01061-1","volume":"25","author":"T Kamath","year":"2022","unstructured":"Kamath T et al (2022) Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson\u2019s disease. Nat Neurosci 25:588\u2013595","journal-title":"Nat Neurosci"},{"key":"5686_CR52","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41583-020-0263-9","volume":"21","author":"AD Greenhalgh","year":"2020","unstructured":"Greenhalgh AD et al (2020) Immune cell regulation of glia during CNS injury and disease. Nat Rev Neurosci 21:139\u2013152","journal-title":"Nat Rev Neurosci"},{"key":"5686_CR53","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/glia.24167","volume":"70","author":"S Sabate-Soler","year":"2022","unstructured":"Sabate-Soler S et al (2022) Microglia integration into human midbrain organoids leads to increased neuronal maturation and functionality. Glia 70:1267\u20131288","journal-title":"Glia"},{"key":"5686_CR54","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.pneurobio.2005.02.001","volume":"75","author":"H Fedorow","year":"2005","unstructured":"Fedorow H et al (2005) Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson\u2019s disease. Prog Neurobiol 75:109\u2013124","journal-title":"Prog Neurobiol"},{"key":"5686_CR55","doi-asserted-by":"publisher","first-page":"11869","DOI":"10.1073\/pnas.97.22.11869","volume":"97","author":"D Sulzer","year":"2000","unstructured":"Sulzer D et al (2000) Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles. Proc Natl Acad Sci U S A 97:11869\u201311874","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5686_CR56","first-page":"256","volume":"95","author":"CD Marsden","year":"1961","unstructured":"Marsden CD (1961) Pigmentation in the nucleus substantiae nigrae of mammals. J Anat 95:256\u2013261","journal-title":"J Anat"},{"key":"5686_CR57","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH et al (1997) Mutation in the \u03b1-synuclein gene identified in families with Parkinson\u2019s disease. Science 276:2045\u20132047","journal-title":"Science"},{"key":"5686_CR58","first-page":"3002","volume":"3","author":"JM George","year":"2002","unstructured":"George JM (2002) The synucleins. Genome Biol 3:3002","journal-title":"Genome Biol"},{"key":"5686_CR59","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG et al (1998) Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies. Proc Natl Acad Sci U S A 95:6469\u20136473","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5686_CR60","doi-asserted-by":"publisher","first-page":"e2109617119","DOI":"10.1073\/pnas.2109617119","volume":"119","author":"SS Ghanem","year":"2022","unstructured":"Ghanem SS et al (2022) \u03b1-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity. Proc Natl Acad Sci U S A 119:e2109617119","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5686_CR61","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00401-017-1792-9","volume":"135","author":"NL Rey","year":"2018","unstructured":"Rey NL et al (2018) Spread of aggregates after olfactory bulb injection of \u03b1-synuclein fibrils is associated with early neuronal loss and is reduced long term. Acta Neuropathol 135:65\u201383","journal-title":"Acta Neuropathol"},{"key":"5686_CR62","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature14547","volume":"522","author":"W Peelaerts","year":"2015","unstructured":"Peelaerts W et al (2015) \u03b1-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 522:340\u2013344","journal-title":"Nature"},{"key":"5686_CR63","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk KC et al (2012) Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338:949\u2013953","journal-title":"Science"},{"key":"5686_CR64","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1084\/jem.20112457","volume":"209","author":"KC Luk","year":"2012","unstructured":"Luk KC et al (2012) Intracerebral inoculation of pathological \u03b1-synuclein initiates a rapidly progressive neurodegenerative \u03b1-synucleinopathy in mice. J Exp Med 209:975\u2013986","journal-title":"J Exp Med"},{"key":"5686_CR65","first-page":"804","volume":"11","author":"L Magistrelli","year":"2021","unstructured":"Magistrelli L et al (2021) The Impact of SNCA variations and its product alpha-synuclein on non-motor features of Parkinson\u2019s Disease. Life (Basel) 11:804","journal-title":"Life (Basel)"},{"key":"5686_CR66","doi-asserted-by":"publisher","first-page":"24475","DOI":"10.1038\/srep24475","volume":"6","author":"IJ Siddiqui","year":"2016","unstructured":"Siddiqui IJ et al (2016) The Parkinson disease gene SNCA: evolutionary and structural insights with pathological implication. Sci Rep 6:24475","journal-title":"Sci Rep"},{"key":"5686_CR67","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3389\/fneur.2018.01021","volume":"9","author":"A Book","year":"2018","unstructured":"Book A et al (2018) A meta-analysis of alpha-synuclein multiplication in familial Parkinsonism. Front Neurol 9:1021","journal-title":"Front Neurol"},{"key":"5686_CR68","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3390\/genes13030471","volume":"13","author":"F Jia","year":"2022","unstructured":"Jia F et al (2022) Monogenic Parkinson\u2019s disease: genotype, phenotype, pathophysiology, and genetic testing. Genes (Basel) 13:471","journal-title":"Genes (Basel)"},{"key":"5686_CR69","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/braincomms\/fcab223","volume":"3","author":"NV Mohamed","year":"2021","unstructured":"Mohamed NV et al (2021) Midbrain organoids with an SNCA gene triplication model key features of synucleinopathy. Brain Commun 3:223","journal-title":"Brain Commun"},{"key":"5686_CR70","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/jnen\/62.12.1241","volume":"62","author":"E Kuusisto","year":"2003","unstructured":"Kuusisto E et al (2003) Morphogenesis of Lewy bodies: dissimilar incorporation of alpha-synuclein, ubiquitin, and p62. J Neuropathol Exp Neurol 62:1241\u20131253","journal-title":"J Neuropathol Exp Neurol"},{"key":"5686_CR71","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1073\/pnas.1913904117","volume":"117","author":"AL Mahul-Mellier","year":"2020","unstructured":"Mahul-Mellier AL et al (2020) The process of Lewy body formation, rather than simply \u03b1-synuclein fibrillization, is one of the major drivers of neurodegeneration. Proc Natl Acad Sci U S A 117:4971\u20134982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5686_CR72","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S0140-6736(05)17829-5","volume":"365","author":"A Di Fonzo","year":"2005","unstructured":"Di Fonzo A et al (2005) A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson\u2019s disease. Lancet 365:412\u2013415","journal-title":"Lancet"},{"key":"5686_CR73","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41582-019-0301-2","volume":"16","author":"E Tolosa","year":"2020","unstructured":"Tolosa E et al (2020) LRRK2 in Parkinson disease: challenges of clinical trials. Nat Rev Neurol 16:97\u2013107","journal-title":"Nat Rev Neurol"},{"key":"5686_CR74","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.stemcr.2019.01.020","volume":"12","author":"H Kim","year":"2019","unstructured":"Kim H et al (2019) Modeling G2019S-LRRK2 sporadic Parkinson\u2019s disease in 3D midbrain organoids. Stem Cell Reports 12:518\u2013531","journal-title":"Stem Cell Reports"},{"key":"5686_CR75","doi-asserted-by":"publisher","first-page":"594090","DOI":"10.3389\/fcell.2020.594090","volume":"8","author":"J Ha","year":"2020","unstructured":"Ha J et al (2020) Simplified brain organoids for rapid and robust modeling of brain disease. Front Cell Dev Biol 8:594090","journal-title":"Front Cell Dev Biol"},{"key":"5686_CR76","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41531-019-0078-4","volume":"5","author":"LM Smits","year":"2019","unstructured":"Smits LM et al (2019) Modeling Parkinson\u2019s disease in midbrain-like organoids. NPJ Parkinsons Dis 5:5","journal-title":"NPJ Parkinsons Dis"},{"key":"5686_CR77","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ajhg.2021.12.009","volume":"109","author":"A Zagare","year":"2022","unstructured":"Zagare A et al (2022) Midbrain organoids mimic early embryonic neurodevelopment and recapitulate LRRK2-p.Gly2019Ser-associated gene expression. Am J Hum Genet 109:311\u2013327","journal-title":"Am J Hum Genet"},{"key":"5686_CR78","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00018-022-04574-x","volume":"79","author":"ZD Zhou","year":"2022","unstructured":"Zhou ZD et al (2022) The role of tyrosine hydroxylase-dopamine pathway in Parkinson\u2019s disease pathogenesis. Cell Mol Life Sci 79:599","journal-title":"Cell Mol Life Sci"},{"key":"5686_CR79","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1212\/WNL.0b013e318225ab77","volume":"77","author":"K Brockmann","year":"2011","unstructured":"Brockmann K, S.K. et al (2011) GBA-associated PD presents with nonmotor characteristics. Neurology 77:276\u2013280","journal-title":"Neurology"},{"key":"5686_CR80","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1136\/jnnp-2020-322857","volume":"91","author":"TB Stoker","year":"2020","unstructured":"Stoker TB et al (2020) Impact of GBA1 variants on long-term clinical progression and mortality in incident Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 91:695\u2013702","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5686_CR81","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/mds.24962","volume":"27","author":"M Poulopoulos","year":"2012","unstructured":"Poulopoulos M et al (2012) The neuropathology of genetic Parkinson\u2019s disease. Mov Disord 27:831\u2013842","journal-title":"Mov Disord"},{"key":"5686_CR82","doi-asserted-by":"publisher","first-page":"9617","DOI":"10.1523\/JNEUROSCI.1525-17.2017","volume":"37","author":"YV Taguchi","year":"2017","unstructured":"Taguchi YV et al (2017) Glucosylsphingosine promotes \u03b1-synuclein pathology in mutant GBA-associated Parkinson\u2019s Disease. J Neurosci 37:9617\u20139631","journal-title":"J Neurosci"},{"key":"5686_CR83","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/ana.26166","volume":"90","author":"J Jo","year":"2021","unstructured":"Jo J et al (2021) Lewy body-like inclusions in human midbrain organoids carrying glucocerebrosidase and alpha-synuclein mutations. Ann Neurol 90:490\u2013505","journal-title":"Ann Neurol"},{"key":"5686_CR84","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s40478-021-01256-w","volume":"9","author":"N Gustavsson","year":"2021","unstructured":"Gustavsson N et al (2021) The intracellular milieu of Parkinson\u2019s disease patient brain cells modulates alpha-synuclein protein aggregation. Acta Neuropathol Commun 9:153","journal-title":"Acta Neuropathol Commun"},{"key":"5686_CR85","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/s41596-022-00787-3","volume":"18","author":"L Concha-Marambio","year":"2023","unstructured":"Concha-Marambio L et al (2023) Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid. Nat Protoc 18:1179\u20131196","journal-title":"Nat Protoc"},{"key":"5686_CR86","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jamaneurol.2016.4547","volume":"74","author":"M Shahnawaz","year":"2017","unstructured":"Shahnawaz M et al (2017) Development of a biochemical diagnosis of Parkinson disease by detection of \u03b1-synuclein misfolded aggregates in cerebrospinal fluid. JAMA Neurol 74:163\u2013172","journal-title":"JAMA Neurol"},{"key":"5686_CR87","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","volume":"22","author":"A Siderowf","year":"2023","unstructured":"Siderowf A et al (2023) Assessment of heterogeneity among participants in the Parkinson\u2019s Progression Markers Initiative cohort using \u03b1-synuclein seed amplification: a cross-sectional study. Lancet Neurol 22:407\u2013417","journal-title":"Lancet Neurol"},{"key":"5686_CR88","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston JW et al (1983) Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219:979\u2013980","journal-title":"Science"},{"key":"5686_CR89","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1016\/0024-3205(85)90146-8","volume":"36","author":"WJ Nicklas","year":"1985","unstructured":"Nicklas WJ et al (1985) Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci 36:2503\u20132508","journal-title":"Life Sci"},{"key":"5686_CR90","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bbadis.2009.08.013","volume":"1802","author":"KF Winklhofer","year":"2010","unstructured":"Winklhofer KF et al (2010) Mitochondrial dysfunction in Parkinson\u2019s disease. Biochim Biophys Acta 1802:29\u201344","journal-title":"Biochim Biophys Acta"},{"key":"5686_CR91","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/stem.3163","volume":"38","author":"TH Kwak","year":"2020","unstructured":"Kwak TH et al (2020) Generation of homogeneous midbrain organoids with in vivo-like cellular composition facilitates neurotoxin-based Parkinson\u2019s disease modeling. Stem Cells 38:727\u2013740","journal-title":"Stem Cells"},{"key":"5686_CR92","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41583-024-00812-2","volume":"25","author":"R Coukos","year":"2024","unstructured":"Coukos R et al (2024) Key genes and convergent pathogenic mechanisms in Parkinson disease. Nat Rev Neurosci 25:393\u2013413","journal-title":"Nat Rev Neurosci"},{"key":"5686_CR93","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pneurobio.2018.09.003","volume":"177","author":"A Grunewald","year":"2019","unstructured":"Grunewald A et al (2019) New insights into the complex role of mitochondria in Parkinson\u2019s disease. Prog Neurobiol 177:73\u201393","journal-title":"Prog Neurobiol"},{"key":"5686_CR94","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.stemcr.2019.12.005","volume":"14","author":"T Ahfeldt","year":"2020","unstructured":"Ahfeldt T et al (2020) Pathogenic pathways in early-onset autosomal recessive Parkinson\u2019s disease discovered using isogenic human dopaminergic neurons. Stem Cell Rep 14:75\u201390","journal-title":"Stem Cell Rep"},{"key":"5686_CR95","doi-asserted-by":"publisher","first-page":"eaau3960","DOI":"10.1126\/scitranslmed.aau3960","volume":"12","author":"I Boussaad","year":"2020","unstructured":"Boussaad I et al (2020) A patient-based model of RNA mis-splicing uncovers treatment targets in Parkinson\u2019s disease. Sci Transl Med 12:eaau3960","journal-title":"Sci Transl Med"},{"key":"5686_CR96","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41531-020-00137-8","volume":"6","author":"M Kano","year":"2020","unstructured":"Kano M et al (2020) Reduced astrocytic reactivity in human brains and midbrain organoids with PRKN mutations. NPJ Parkinsons Dis 6:33","journal-title":"NPJ Parkinsons Dis"},{"key":"5686_CR97","doi-asserted-by":"publisher","first-page":"780207","DOI":"10.3389\/fcell.2021.780207","volume":"9","author":"RM Fame","year":"2021","unstructured":"Fame RM et al (2021) Mitochondria in early forebrain development: from neurulation to mid-corticogenesis. Front Cell Dev Biol 9:780207","journal-title":"Front Cell Dev Biol"},{"key":"5686_CR98","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/dvdy.24538","volume":"247","author":"M Khacho","year":"2018","unstructured":"Khacho M et al (2018) Mitochondrial dynamics in the regulation of neurogenesis: from development to the adult brain. Dev Dyn 247:47\u201353","journal-title":"Dev Dyn"},{"key":"5686_CR99","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1126\/science.aba9760","volume":"369","author":"R Iwata","year":"2020","unstructured":"Iwata R et al (2020) Mitochondrial dynamics in postmitotic cells regulate neurogenesis. Science 369:858\u2013862","journal-title":"Science"},{"key":"5686_CR100","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jchemneu.2010.11.004","volume":"41","author":"M d'Amora","year":"2011","unstructured":"d\u2019Amora M et al (2011) Expression of PINK1 in the brain, eye and ear of mouse during embryonic development. J Chem Neuroanat 41:73\u201385","journal-title":"J Chem Neuroanat"},{"key":"5686_CR101","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ijdevneu.2010.04.002","volume":"28","author":"S Zechel","year":"2010","unstructured":"Zechel S et al (2010) Expression of leucine-rich-repeat-kinase 2 (LRRK2) during embryonic development. Int J Dev Neurosci 28:391\u2013399","journal-title":"Int J Dev Neurosci"},{"key":"5686_CR102","doi-asserted-by":"publisher","first-page":"6617","DOI":"10.1038\/s41598-021-84278-7","volume":"11","author":"SJ Brown","year":"2021","unstructured":"Brown SJ et al (2021) PINK1 deficiency impairs adult neurogenesis of dopaminergic neurons. Sci Rep 11:6617","journal-title":"Sci Rep"},{"key":"5686_CR103","first-page":"15","volume":"37","author":"J Jarazo","year":"2019","unstructured":"Jarazo J et al (2019) Parkinson\u2019s disease phenotypes in patient neuronal cultures and brain organoids improved by 2-hydroxypropyl-\u03b2-cyclodextrin treatment. Mov Disord 37:15","journal-title":"Mov Disord"},{"key":"5686_CR104","doi-asserted-by":"publisher","first-page":"6217","DOI":"10.1039\/D2SC00809B","volume":"13","author":"W Zhu","year":"2022","unstructured":"Zhu W et al (2022) Dysfunction of vesicular storage in young-onset Parkinson\u2019s patient-derived dopaminergic neurons and organoids revealed by single cell electrochemical cytometry. Chem Sci 13:6217\u20136223","journal-title":"Chem Sci"},{"key":"5686_CR105","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abb1540","volume-title":"Neurodevelopmental defects and neurodegenerative phenotypes in human brain organoids carrying Parkinson's disease-linked DNAJC6 mutations","author":"N Wulansari","year":"2021","unstructured":"Wulansari N et al (2021) Neurodevelopmental defects and neurodegenerative phenotypes in human brain organoids carrying Parkinson\u2019s disease-linked DNAJC6 mutations. Adv, Sci. https:\/\/doi.org\/10.1126\/sciadv.abb1540"},{"key":"5686_CR106","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.stem.2009.09.015","volume":"5","author":"S Chung","year":"2009","unstructured":"Chung S et al (2009) Wnt1-lmx1a forms a novel autoregulatory loop and controls midbrain dopaminergic differentiation synergistically with the SHH-FoxA2 pathway. Cell Stem Cell 5:646\u2013658","journal-title":"Cell Stem Cell"},{"key":"5686_CR107","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00018-014-1774-1","volume":"72","author":"JN Le Grand","year":"2015","unstructured":"Le Grand JN et al (2015) Neural stem cells in Parkinson\u2019s disease: a role for neurogenesis defects in onset and progression. Cell Mol Life Sci 72:773\u2013797","journal-title":"Cell Mol Life Sci"},{"key":"5686_CR108","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1089\/scd.2017.0289","volume":"27","author":"JC Schwamborn","year":"2018","unstructured":"Schwamborn JC (2018) Is Parkinson\u2019s Disease a neurodevelopmental disorder and will brain organoids help us to understand it? Stem Cells Dev 27:968\u2013975","journal-title":"Stem Cells Dev"},{"key":"5686_CR109","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/path.4328","volume":"232","author":"BR Smith","year":"2014","unstructured":"Smith BR et al (2014) Neuronal inclusions of \u03b1-synuclein contribute to the pathogenesis of Krabbe disease. J Pathol 232:509\u2013521","journal-title":"J Pathol"},{"key":"5686_CR110","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.neurobiolaging.2010.05.009","volume":"33","author":"C Pais\u00e1n-Ruiz","year":"2012","unstructured":"Pais\u00e1n-Ruiz C et al (2012) Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations. Neurobiol Aging 33:814\u2013823","journal-title":"Neurobiol Aging"},{"key":"5686_CR111","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3390\/ijms21030694","volume":"21","author":"P Chlebanowska","year":"2020","unstructured":"Chlebanowska P et al (2020) Use of 3D organoids as a model to study idiopathic form of Parkinson\u2019s Disease. Int J Mol Sci 21:694","journal-title":"Int J Mol Sci"},{"key":"5686_CR112","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","volume":"46","author":"JW Langston","year":"1999","unstructured":"Langston JW et al (1999) Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann Neurol 46:598\u2013605","journal-title":"Ann Neurol"},{"key":"5686_CR113","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/35072550","volume":"2","author":"MF Beal","year":"2001","unstructured":"Beal MF (2001) Experimental models of Parkinson\u2019s disease. Nat Rev Neurosci 2:325\u2013334","journal-title":"Nat Rev Neurosci"},{"key":"5686_CR114","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.parkreldis.2020.05.011","volume":"75","author":"AS Monzel","year":"2020","unstructured":"Monzel AS et al (2020) Machine learning-assisted neurotoxicity prediction in human midbrain organoids. Parkinsonism Relat Disord 75:105\u2013109","journal-title":"Parkinsonism Relat Disord"},{"key":"5686_CR115","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1002\/mds.28246","volume":"35","author":"SJ Chen","year":"2020","unstructured":"Chen SJ et al (2020) The gut metabolite trimethylamine n-oxide is associated with Parkinson\u2019s disease severity and Progression. Mov Disord 35:2115\u20132116","journal-title":"Mov Disord"},{"key":"5686_CR116","doi-asserted-by":"publisher","first-page":"925227","DOI":"10.3389\/fnagi.2022.925227","volume":"14","author":"Y Lee","year":"2022","unstructured":"Lee Y et al (2022) Gut metabolite trimethylamine N-oxide induces aging-associated phenotype of midbrain organoids for the induced pluripotent stem cell-based modeling of late-onset disease. Front Aging Neurosci 14:925227","journal-title":"Front Aging Neurosci"},{"issue":"Suppl 1","key":"5686_CR117","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1017\/cjn.2016.2","volume":"43","author":"DB Hogan","year":"2016","unstructured":"Hogan DB et al (2016) The prevalence and incidence of dementia with Lewy bodies: a systematic review. Can J Neurol Sci 43(Suppl 1):S83\u2013S95","journal-title":"Can J Neurol Sci"},{"key":"5686_CR118","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG et al (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 89:88\u2013100","journal-title":"Neurology"},{"key":"5686_CR119","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-019-0306-8","volume":"14","author":"TF Outeiro","year":"2019","unstructured":"Outeiro TF et al (2019) Dementia with Lewy bodies: an update and outlook. Mol Neurodegener 14:5","journal-title":"Mol Neurodegener"},{"key":"5686_CR120","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11910-018-0874-y","volume":"18","author":"T Orme","year":"2018","unstructured":"Orme T et al (2018) The genetics of dementia with Lewy bodies: current understanding and future directions. Curr Neurol Neurosci Rep 18:67","journal-title":"Curr Neurol Neurosci Rep"},{"key":"5686_CR121","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/bpa.12182","volume":"25","author":"DR Howlett","year":"2015","unstructured":"Howlett DR et al (2015) Regional multiple pathology scores are associated with cognitive decline in Lewy body dementias. Brain Pathol 25:401\u2013408","journal-title":"Brain Pathol"},{"key":"5686_CR122","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00401-008-0347-5","volume":"115","author":"KA Jellinger","year":"2008","unstructured":"Jellinger KA et al (2008) Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease. Acta Neuropathol 115:427\u2013436","journal-title":"Acta Neuropathol"},{"key":"5686_CR123","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00401-017-1755-1","volume":"134","author":"N Bengoa-Vergniory","year":"2017","unstructured":"Bengoa-Vergniory N et al (2017) Alpha-synuclein oligomers: a new hope. Acta Neuropathol 134:819\u2013838","journal-title":"Acta Neuropathol"},{"key":"5686_CR124","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1073\/pnas.1100976108","volume":"108","author":"B Winner","year":"2011","unstructured":"Winner B et al (2011) In vivo demonstration that alpha-synuclein oligomers are toxic. Proc Natl Acad Sci U S A 108:4194\u20134199","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5686_CR125","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/BF00695605","volume":"64","author":"P Gaspar","year":"1984","unstructured":"Gaspar P et al (1984) Dementia in idiopathic Parkinson\u2019s disease. A neuropathological study of 32 cases. Acta Neuropathol 64:43\u201352","journal-title":"Acta Neuropathol"},{"key":"5686_CR126","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/mds.25857","volume":"29","author":"GM Halliday","year":"2014","unstructured":"Halliday GM et al (2014) The neurobiological basis of cognitive impairment in Parkinson\u2019s disease. Mov Disord 29:634\u2013650","journal-title":"Mov Disord"},{"key":"5686_CR127","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1136\/jnnp.48.5.413","volume":"48","author":"EK Perry","year":"1985","unstructured":"Perry EK et al (1985) Cholinergic correlates of cognitive impairment in Parkinson\u2019s disease: comparisons with Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 48:413\u2013421","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5686_CR128","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.pneurobio.2009.02.004","volume":"88","author":"I Ferrer","year":"2009","unstructured":"Ferrer I (2009) Early involvement of the cerebral cortex in Parkinson\u2019s disease: convergence of multiple metabolic defects. Prog Neurobiol 88:89\u2013103","journal-title":"Prog Neurobiol"},{"key":"5686_CR129","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1212\/01.wnl.0000304050.05332.9c","volume":"70","author":"C Huang","year":"2008","unstructured":"Huang C et al (2008) Metabolic abnormalities associated with mild cognitive impairment in Parkin son disease. Neurology 70:1470\u20131477","journal-title":"Neurology"},{"key":"5686_CR130","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.brainres.2007.10.061","volume":"1189","author":"WD Parker","year":"2008","unstructured":"Parker WD et al (2008) Complex I deficiency in Parkinson\u2019s disease frontal cortex. Brain Res 1189:215\u2013218","journal-title":"Brain Res"},{"key":"5686_CR131","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.neulet.2007.01.026","volume":"415","author":"I Ferrer","year":"2007","unstructured":"Ferrer I et al (2007) Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson\u2019s disease. Neurosci Lett 415:205\u2013209","journal-title":"Neurosci Lett"},{"key":"5686_CR132","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41593-021-00802-y","volume":"24","author":"A Gordon","year":"2021","unstructured":"Gordon A et al (2021) Long-term maturation of human cortical organoids matches key early postnatal transitions. Nat Neurosci 24:331\u2013342","journal-title":"Nat Neurosci"},{"key":"5686_CR133","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s41586-019-1654-9","volume":"574","author":"S Kanton","year":"2019","unstructured":"Kanton S et al (2019) Organoid single-cell genomic atlas uncovers human-specific features of brain development. Nature 574:418\u2013422","journal-title":"Nature"},{"key":"5686_CR134","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1126\/scitranslmed.aay1809","volume":"12","author":"N Zhao","year":"2020","unstructured":"Zhao N et al (2020) APOE4 exacerbates \u03b1-synuclein pathology and related toxicity independent of amyloid. Sci Transl Med 12:1809","journal-title":"Sci Transl Med"},{"key":"5686_CR135","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S1474-4422(17)30400-3","volume":"17","author":"R Guerreiro","year":"2018","unstructured":"Guerreiro R et al (2018) Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study. Lancet Neurol 17:64\u201374","journal-title":"Lancet Neurol"},{"key":"5686_CR136","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.parkreldis.2016.07.015","volume":"31","author":"MG Heckman","year":"2016","unstructured":"Heckman MG et al (2016) LRRK2 variation and dementia with Lewy bodies. Parkinsonism Relat Disord 31:98\u2013103","journal-title":"Parkinsonism Relat Disord"},{"key":"5686_CR137","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1001\/jamaneurol.2016.1593","volume":"73","author":"T Shiner","year":"2016","unstructured":"Shiner T et al (2016) High frequency of GBA gene mutations in dementia with lewy bodies among Ashkenazi Jews. JAMA Neurol 73:1448\u20131453","journal-title":"JAMA Neurol"},{"key":"5686_CR138","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13041-021-00864-w","volume":"14","author":"ST Foliaki","year":"2021","unstructured":"Foliaki ST et al (2021) Neuronal excitatory-to-inhibitory balance is altered in cerebral organoid models of genetic neurological diseases. Mol Brain 14:156","journal-title":"Mol Brain"},{"key":"5686_CR139","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41380-022-01892-1","volume":"28","author":"W Zhang","year":"2023","unstructured":"Zhang W et al (2023) Microglia-containing human brain organoids for the study of brain development and pathology. Mol Psychiatry 28:96\u2013107","journal-title":"Mol Psychiatry"},{"issue":"278\u2013293","key":"5686_CR140","first-page":"e9","volume":"94","author":"EM Abud","year":"2017","unstructured":"Abud EM et al (2017) iPSC-derived human microglia-like cells to study neurological diseases. Neuron 94(278\u2013293):e9","journal-title":"Neuron"},{"key":"5686_CR141","doi-asserted-by":"publisher","first-page":"11055","DOI":"10.1038\/s41598-019-47444-6","volume":"9","author":"L Song","year":"2019","unstructured":"Song L et al (2019) Functionalization of brain region-specific spheroids with isogenic microglia-like cells. Sci Rep 9:11055","journal-title":"Sci Rep"},{"key":"5686_CR142","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1039\/D1LC00030F","volume":"21","author":"Z Ao","year":"2021","unstructured":"Ao Z et al (2021) Tubular human brain organoids to model microglia-mediated neuroinflammation. Lab Chip 21:2751\u20132762","journal-title":"Lab Chip"},{"key":"5686_CR143","doi-asserted-by":"publisher","first-page":"4167","DOI":"10.1038\/s41467-018-06684-2","volume":"9","author":"PR Ormel","year":"2018","unstructured":"Ormel PR et al (2018) Microglia innately develop within cerebral organoids. Nat Commun 9:4167","journal-title":"Nat Commun"},{"key":"5686_CR144","doi-asserted-by":"publisher","first-page":"105698","DOI":"10.1016\/j.nbd.2022.105698","volume":"168","author":"J Amin","year":"2022","unstructured":"Amin J et al (2022) Inflammation in dementia with Lewy bodies. Neurobiol Dis 168:105698","journal-title":"Neurobiol Dis"},{"key":"5686_CR145","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.3390\/cells9071687","volume":"9","author":"M Pajares","year":"2020","unstructured":"Pajares M et al (2020) Inflammation in Parkinson\u2019s disease: mechanisms and therapeutic implications. Cells 9:1687","journal-title":"Cells"},{"key":"5686_CR146","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41592-018-0081-4","volume":"15","author":"M Madhavan","year":"2018","unstructured":"Madhavan M et al (2018) Induction of myelinating oligodendrocytes in human cortical spheroids. Nat Methods 15:700\u2013706","journal-title":"Nat Methods"},{"key":"5686_CR147","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/s41593-018-0316-9","volume":"22","author":"RM Marton","year":"2019","unstructured":"Marton RM et al (2019) Differentiation and maturation of oligodendrocytes in human three-dimensional neural cultures. Nat Neurosci 22:484\u2013491","journal-title":"Nat Neurosci"},{"key":"5686_CR148","doi-asserted-by":"publisher","first-page":"631548","DOI":"10.3389\/fncel.2021.631548","volume":"15","author":"MR Shaker","year":"2021","unstructured":"Shaker MR et al (2021) Rapid and efficient generation of myelinating human oligodendrocytes in organoids. Front Cell Neurosci 15:631548","journal-title":"Front Cell Neurosci"},{"key":"5686_CR149","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/s41592-019-0586-5","volume":"16","author":"B Cakir","year":"2019","unstructured":"Cakir B et al (2019) Engineering of human brain organoids with a functional vascular-like system. Nat Methods 16:1169\u20131175","journal-title":"Nat Methods"},{"key":"5686_CR150","doi-asserted-by":"publisher","first-page":"e76707","DOI":"10.7554\/eLife.76707","volume":"11","author":"XY Sun","year":"2022","unstructured":"Sun XY et al (2022) Generation of vascularized brain organoids to study neurovascular interactions. Elife 11:e76707","journal-title":"Elife"},{"key":"5686_CR151","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.bbrc.2019.10.079","volume":"521","author":"O Ham","year":"2020","unstructured":"Ham O et al (2020) Blood vessel formation in cerebral organoids formed from human embryonic stem cells. Biochem Biophys Res Commun 521:84\u201390","journal-title":"Biochem Biophys Res Commun"},{"key":"5686_CR152","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202000825","volume":"9","author":"G Kaushik","year":"2020","unstructured":"Kaushik G et al (2020) Engineered perineural vascular plexus for modeling developmental toxicity. Adv Healthc Mater 9:e2000825","journal-title":"Adv Healthc Mater"},{"key":"5686_CR153","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.3390\/cells10082036","volume":"10","author":"Y Ahn","year":"2021","unstructured":"Ahn Y et al (2021) Human blood vessel organoids penetrate human cerebral organoids and form a vessel-like system. Cells 10:2036","journal-title":"Cells"},{"key":"5686_CR154","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000705","volume":"18","author":"Y Shi","year":"2020","unstructured":"Shi Y et al (2020) Vascularized human cortical organoids (vOrganoids) model cortical development in vivo. PloS Biol 18:e3000705","journal-title":"PloS Biol"},{"key":"5686_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibtech.2024.11.021","author":"L Kistemaker","year":"2025","unstructured":"Kistemaker L et al (2025) Vascularized human brain organoids: current possibilities and prospects. Trends Biotechnol. https:\/\/doi.org\/10.1016\/j.tibtech.2024.11.021","journal-title":"Trends Biotechnol"},{"key":"5686_CR156","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.637048","volume":"9","author":"X Zhao","year":"2021","unstructured":"Zhao X et al (2021) Review on the vascularization of organoids and organoids-on-a-chip. Front Bioeng Biotechnol 9:637048","journal-title":"Front Bioeng Biotechnol"},{"key":"5686_CR157","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nmeth.4304","volume":"14","author":"JA Bagley","year":"2017","unstructured":"Bagley JA et al (2017) Fused cerebral organoids model interactions between brain regions. Nat Methods 14:743\u2013751","journal-title":"Nat Methods"},{"key":"5686_CR158","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1038\/s41587-020-00763-w","volume":"38","author":"Y Miura","year":"2020","unstructured":"Miura Y et al (2020) Generation of human striatal organoids and cortico-striatal assembloids from human pluripotent stem cells. Nat Biotechnol 38:1421\u20131430","journal-title":"Nat Biotechnol"},{"key":"5686_CR159","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nature22047","volume":"545","author":"G Quadrato","year":"2017","unstructured":"Quadrato G et al (2017) Cell diversity and network dynamics in photosensitive human brain organoids. Nature 545:48\u201353","journal-title":"Nature"},{"key":"5686_CR160","doi-asserted-by":"publisher","first-page":"4403","DOI":"10.1038\/s41467-022-32115-4","volume":"13","author":"T Sharf","year":"2022","unstructured":"Sharf T et al (2022) Functional neuronal circuitry and oscillatory dynamics in human brain organoids. Nat Commun 13:4403","journal-title":"Nat Commun"},{"key":"5686_CR161","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41593-019-0350-2","volume":"22","author":"SL Giandomenico","year":"2019","unstructured":"Giandomenico SL et al (2019) Cerebral organoids at the air-liquid interface generate diverse nerve tracts with functional output. Nat Neurosci 22:669\u2013679","journal-title":"Nat Neurosci"},{"issue":"766\u2013781","key":"5686_CR162","first-page":"e9","volume":"26","author":"X Qian","year":"2020","unstructured":"Qian X et al (2020) Sliced human cortical organoids for modeling distinct cortical layer formation. Cell Stem Cell 26(766\u2013781):e9","journal-title":"Cell Stem Cell"},{"key":"5686_CR163","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ydbio.2017.02.002","volume":"423","author":"C Barry","year":"2017","unstructured":"Barry C et al (2017) Species-specific developmental timing is maintained by pluripotent stem cells ex utero. Dev Biol 423:101\u2013110","journal-title":"Dev Biol"},{"key":"5686_CR164","doi-asserted-by":"publisher","first-page":"e37527","DOI":"10.7554\/eLife.37527","volume":"8","author":"MC Marchetto","year":"2019","unstructured":"Marchetto MC et al (2019) Species-specific maturation profiles of human, chimpanzee and bonobo neural cells. Elife 8:e37527","journal-title":"Elife"},{"key":"5686_CR165","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1038\/s41587-024-02233-z","volume":"42","author":"E Hergenreder","year":"2024","unstructured":"Hergenreder E et al (2024) Combined small-molecule treatment accelerates maturation of human pluripotent stem cell-derived neurons. Nat Biotechnol 42:1615","journal-title":"Nat Biotechnol"},{"key":"5686_CR166","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.neuron.2013.05.029","volume":"78","author":"Y Zhang","year":"2013","unstructured":"Zhang Y et al (2013) Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron 78:785\u2013798","journal-title":"Neuron"},{"issue":"2886\u20132909","key":"5686_CR167","first-page":"e16","volume":"112","author":"I Lam","year":"2024","unstructured":"Lam I et al (2024) Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of \u03b1-synuclein inclusions. Neuron 112(2886\u20132909):e16","journal-title":"Neuron"},{"key":"5686_CR168","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1146\/annurev-genet-120417-031534","volume":"52","author":"J Mertens","year":"2018","unstructured":"Mertens J et al (2018) Aging in a Dish: iPSC-derived and directly induced neurons for studying brain aging and age-related neurodegenerative diseases. Annu Rev Genet 52:271\u2013293","journal-title":"Annu Rev Genet"},{"key":"5686_CR169","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.stem.2013.11.006","volume":"13","author":"JD Miller","year":"2013","unstructured":"Miller JD et al (2013) Human iPSC-based modeling of late-onset disease via progerin-induced aging. Cell Stem Cell 13:691\u2013705","journal-title":"Cell Stem Cell"},{"key":"5686_CR170","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.celrep.2016.09.062","volume":"17","author":"E Vera","year":"2016","unstructured":"Vera E et al (2016) Generating late-onset human iPSC-based disease models by inducing neuronal age-related phenotypes through telomerase manipulation. Cell Rep 17:1184\u20131192","journal-title":"Cell Rep"},{"key":"5686_CR171","doi-asserted-by":"publisher","first-page":"e13541","DOI":"10.1111\/acel.13541","volume":"21","author":"A Fathi","year":"2022","unstructured":"Fathi A et al (2022) Chemically induced senescence in human stem cell-derived neurons promotes phenotypic presentation of neurodegeneration. Aging Cell 21:e13541","journal-title":"Aging Cell"},{"issue":"137\u2013152","key":"5686_CR172","first-page":"e7","volume":"30","author":"D Jgamadze","year":"2023","unstructured":"Jgamadze D et al (2023) Structural and functional integration of human forebrain organoids with the injured adult rat visual system. Cell Stem Cell 30(137\u2013152):e7","journal-title":"Cell Stem Cell"},{"key":"5686_CR173","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/nbt.4127","volume":"36","author":"AA Mansour","year":"2018","unstructured":"Mansour AA et al (2018) An in vivo model of functional and vascularized human brain organoids. Nat Biotechnol 36:432\u2013441","journal-title":"Nat Biotechnol"},{"key":"5686_CR174","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41586-022-05277-w","volume":"610","author":"O Revah","year":"2022","unstructured":"Revah O et al (2022) Maturation and circuit integration of transplanted human cortical organoids. Nature 610:319\u2013326","journal-title":"Nature"},{"issue":"2111\u20132126","key":"5686_CR175","first-page":"e20","volume":"186","author":"ST Schafer","year":"2023","unstructured":"Schafer ST et al (2023) An in vivo neuroimmune organoid model to study human microglia phenotypes. Cell 186(2111\u20132126):e20","journal-title":"Cell"},{"key":"5686_CR176","doi-asserted-by":"publisher","DOI":"10.1038\/s44222-023-00063-3","author":"A Loewa","year":"2023","unstructured":"Loewa A et al (2023) Human disease models in drug development. Nat Rev Bioeng. https:\/\/doi.org\/10.1038\/s44222-023-00063-3","journal-title":"Nat Rev Bioeng"},{"key":"5686_CR177","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2901-9","volume":"589","author":"Y Han","year":"2021","unstructured":"Han Y et al (2021) Identification of SARS-CoV-2 inhibitors using lung and colonic organoids. Nature 589:270\u2013275","journal-title":"Nature"},{"key":"5686_CR178","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s43018-022-00359-0","volume":"3","author":"B Herpers","year":"2022","unstructured":"Herpers B et al (2022) Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR \u00d7 LGR5 bispecific antibody with efficacy in epithelial tumors. Nat Cancer 3:418\u2013436","journal-title":"Nat Cancer"},{"key":"5686_CR179","doi-asserted-by":"publisher","first-page":"e175824","DOI":"10.1172\/JCI175824","volume":"133","author":"PH Zushin","year":"2023","unstructured":"Zushin PH et al (2023) FDA Modernization Act 2.0: transitioning beyond animal models with human cells, organoids, and AI\/ML-based approaches. J Clin Invest 133:e175824","journal-title":"J Clin Invest"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05686-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-025-05686-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05686-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T07:03:27Z","timestamp":1745823807000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-025-05686-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":179,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5686"],"URL":"https:\/\/doi.org\/10.1007\/s00018-025-05686-w","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"assertion":[{"value":"16 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"The authors declare no competing interests in relation to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"188"}}